Stan Bukofzer insider trades: Assertio Therapeutics (ASRT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stan reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | ASRT | ↑ Buy | 4,000 | $1.56 | $6K | Direct | Aug 14, 2019 (1d) |
| Mar 14, 2019 | ASRT | ↑ Buy | 5,000 | $4.13 | $21K | Direct | Mar 18, 2019 (4d) |
| Oct 13, 2016 | OCRX | ↑ Buy | 2,500 | $2.64 | $7K | Direct | Oct 17, 2016 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ASRT insiders
Open-market trades in the last 12 months
About Stan Bukofzer's insider trades
Stan Bukofzer is SVP, Chf Scitfc & Tech Officer at Assertio Therapeutics (ASRT). Since Oct 13, 2016, Stan has reported 3 open-market purchases worth $33K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), shares withheld for taxes (3 filings), option exercises (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ASRT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.